Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Behr, J; Berger, M; Blum, TG; Bonella, F; Dinkel, J; Gläser, S; Hagmeyer, L; Kneidinger, N; Koschel, D; Prasse, A; Slevogt, H; Stacher-Priehse, E; Woehrle, H; Kreuter, M.
[SARS-CoV-2-Infection and Interstitial Lung Disease: Position paper of the German Respiratory Society].
Pneumologie. 2023; 77(3): 143-157.
Doi: 10.1055/a-2007-9845
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Kneidinger Nikolaus
- Stacher-Priehse Elvira
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The SARS-CoV-2 pandemic had a tremendous impact on diagnosis and treatment of interstitial lung diseases (ILD). Especially in the early phase of the pandemic, when the delta variant was prevailling, a huge number of viral pneumonias were observed, which worsened pre-existing, triggered de novo occurence or discovery of previously subclincal interstitial lung diseases. The effect of SARS-CoV-2 infection - without or with accompanying viral pneumonia - on the further development of pre-existing ILD as well of new pulmonary inflitrates and consolidiations is difficult to predict and poses a daily challenge to interdisciplinary ILD boards. This position paper of the German Respiratory Society (DGP e.V.) provides answers to the most pressing questions based on current knowledge.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- COVID-19 - administration & dosage
- SARS-CoV-2 - administration & dosage
- Lung Diseases, Interstitial - diagnosis, therapy
- Lung - administration & dosage
- Pneumonia, Viral - diagnosis, epidemiology, therapy
- Find related publications in this database (Keywords)
- COVID-19
- SARS-CoV-2
- interstitial lung disease
- pulmonary fibrosis
- diagnosis and therapy